Global Enteric Disease Testing - Treatment Market By Disease Type (Bacterial Enteric Diseases, Viral Enteric Diseases, Parasitic Enteric Diseases), Therapeutics (Campylobacter, Cryptosporidium, E-Coli, Enteroviruses, RhinoViruses, RotaVirus, Salmonellosis, Shigellosis), Testing Technology (Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, Differential Light Scanning, Information Technology, AI, Liposomes, Flow Cytometry, Chromatography, Diagnostic Imaging, Gel Microdroplets, Others), End User (Hospitals, Diagnostic Laboratories, Physician Offices), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa), Industry Trends and Forecast to 2027
Market Analysis and Insights: Global Enteric Disease Testing-Treatment Market
Enteric disease testing-treatment market is expected to account to USD 5.27 billion by 2027 expanding at a rate of 3.8% in the forecast period of 2020 to 2027. The market is expected to witness rapid expansion in terms of its capitalization as the major market players are focusing on development of products that help physicians and patients in a better healthcare delivery.
Enteric diseases are the category of intestinal diseases generally caused by the prevalence of different micro-organisms such as parasites, viruses and bacteria. These micro-organisms are generally prevalent in different forms of food products and water bodies, with this disease category also communicable between individuals. Enteric disease testing and treatment are the various diagnosis and therapeutic solutions provided by the various market players to reduce or remove the impact of enteric diseases from the human body.
Increasing volume of patients suffering from target diseases is acting as a significant driver for the growth of enteric disease testing–treatment market in the forecasted period of 2020 to 2027. Availability of a better quality of products that are based on advanced technologies rather than conventional methods, this factor is also driving the market’s growth.
Stringent regulatory requirements in relation to diagnostic conditions for testing along with the high costs associated with the equipment and labour are expected to hinder the market’s growth in the above-mentioned forecasted period of 2020 to 2027.
This enteric disease testing-treatment market report provides details of market share, new developments, product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief our team will help you create a revenue impact solution to achieve your desired goal.
Enteric Disease Testing-Treatment Market Scope and Market Size
Enteric disease testing - treatment market is segmented on the basis of disease type, therapeutics, testing technology and end user. Each individual segment’s growth is analysed and these insights are subsequently considered before providing you with the market overview which can help you in understanding and identification of your core applications in the broad market.
On the basis of disease type, the enteric disease testing - treatment market has been segmented into bacterial enteric diseases, viral enteric diseases and parasitic enteric diseases. Bacterial enteric diseases have been further segmented into C.difficile infection, campylobacteriosis, cholera, E.coli infection, H.pylori infection, salmonellosis and shigellosis. Viral enteric diseases have been sub-segmented into rotavirus infection and norovirus infection. Parasitic enteric diseases have segmented into amebiasis, cryptosporidiosis and giardiasis.
Based on therapeutics, the enteric disease testing - treatment market has been segmented into campylobacter, cryptosporidium, E-Coli, enteroviruses, RhinoViruses, RotaVirus (REOVIRUS), salmonellosis and shigellosis.
Enteric disease testing-treatment market has been segmented on the basis of testing technology into molecular diagnostics, monoclonal antibodies, immunoassays, differential light scanning, information technology, artificial intelligence (AI), liposomes, flow cytometry, chromatography, diagnostic imaging, gel microdroplets, others
Based on end user, the enteric disease testing-treatment market has been segmented into hospitals, diagnostic laboratories and physician offices.
Enteric Disease Testing-Treatment Market Country Level Analysis
Enteric disease testing - treatment market is analysed and market size information is provided by country, disease type, therapeutics, testing technology and end user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa as a part of Middle East & Africa, Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific will be the most dominant region for enteric disease testing-treatment market with a majority of the population living in urban areas suffering from some form of enteric diseases. This population is also migrating towards urban areas which have resulted in high demands for better quality of healthcare services such as diagnostic products, treatment and other solutions.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Enteric disease testing-treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for enteric disease testing-treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the enteric disease testing market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Enteric Disease Testing-Treatment Market Share Analysis
Enteric disease testing-treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to enteric disease testing market.
The major players covered in the report are Abbott, BD, Biomerica, Inc., bioMérieux SA, Bio-Rad Laboratories, Inc., Cepheid, CorisBioconcept SPRL, DIASORIN S.p.A., Meridian Bioscience, Inc., Quest Diagnostics Incorporated, Trinity Biotech Ireland, Thermo Fisher Scientific Inc., Mobidiag Ltd., R-Biopharm, GlaxoSmithKline plc, Bharat Biotech, Sanofi, Janssen Global Services, LLC, Eli Lilly and Company, IDL Biotech AB (publ), Merck & Co., Inc., Novartis AG, Takeda Pharmaceutical Company Limited among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Enteric Disease Testing-Treatment Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.